Financial & Transaction Professionals
Regulatory standing, governance weakness and operational instability can materially affect the viability of a care-sector transaction even where financial performance appears acceptable.
Oxara independently assesses the regulated service behind the financial information, identifying liabilities, registration risks, leadership weaknesses and likely remediation requirements for consideration by the appointed financial, legal and transaction advisers.
What regulatory risk means in a care asset
For a care-sector acquisition or investment, regulatory due diligence should establish whether the target's CQC position, registration, governance, leadership, staffing, quality systems and operational evidence support the business being presented to the buyer or investor, and identify liabilities or remediation requirements that may affect completion, pricing, funding or post-acquisition risk.
Regulatory risk in a care asset is the risk that weaknesses in registration, governance, leadership, clinical practice, staffing, premises or regulatory history may restrict service operation, require remediation, delay a transaction or expose the incoming operator to enforcement.
Financial due diligence tests the financial and commercial information available to the appointed advisers. Oxara's work separately assesses the regulated service, including its governance, registration, operational condition, premises and evidence of compliance.
When financial and transaction professionals instruct Oxara
Financial and transaction professionals may instruct Oxara where:
- an acquisition or investment turns on whether the regulatory standing of the target service could affect its viability;
- latent regulatory liabilities or remediation exposure may affect deal assumptions, pricing discussions or downside analysis;
- an insolvency or restructuring appointment requires a rapid compliance baseline before options are assessed;
- a distressed asset's disposal or continuity options may be restricted by regulatory deterioration;
- transaction timing depends on registration continuity, variation or new registration;
- emerging regulatory risk across a portfolio or lending book requires independent assessment before enforcement restricts available options;
- urgent stabilisation is required to preserve viable transaction or continuity options.
Where the instruction concerns the regulatory suitability of the property itself rather than the trading service, see Care Property Due Diligence and Property & Built Environment Professionals.
If one of these describes the matter in front of you, a director will confirm conflicts, scope and availability.
Discuss a Transaction Matter
Professional Workstreams
Operational & Regulatory Due Diligence
Focus: Transaction risk, liability exposure and registration continuity.
For acquisition, investment and funding instructions, this establishes the regulatory standing of the target service: existing liabilities and registration conditions, the stability of leadership and governance, and the likely scope of remediation before or after completion. Governance and leadership weakness are treated as factors that may materially affect post-acquisition regulatory risk, not as predictions of enforcement. A purchaser may inherit regulatory and operational weaknesses that were not apparent from financial information or headline CQC ratings alone.
The output is regulatory and operational evidence for consideration within pricing, funding and downside-risk discussions led by the appointed advisers.
The full scope, method and reporting structure are set out on the dedicated Operational & Regulatory Due Diligence service page.
What the assessment examines
Depending on the instruction, Oxara's review may draw on:
- CQC reports and enforcement correspondence;
- registration details and conditions;
- governance records;
- quality and clinical audits;
- staffing and leadership data;
- complaints and safeguarding trends;
- commissioner correspondence;
- service-improvement plans;
- premises information;
- operational performance indicators.
The evidence reviewed is determined by the agreed scope, information availability and stage of the transaction or restructuring matter.
Insolvency & Restructuring
Focus: Regulatory stability and disposal viability.
Baseline at Appointment: A rapid compliance baseline following the appointment of an insolvency practitioner, establishing a clear position of risk and compliance exposure to inform the practitioner's assessment of operational and regulatory priorities.
Regulatory Factors Affecting Disposal Options: Identifying operational failures that may accelerate regulatory deterioration or reduce disposal options, allowing the appointed team to consider appropriate stabilisation and transaction measures.
Registration Continuity: Registration requirements and transition risks are assessed during the disposal process, with operational and evidential support provided to the appointed team where continuity, variation or new registration may affect transaction timing and service viability.
Portfolio & Lender Risk Assessment
Focus: Ongoing monitoring and early risk identification.
For a lender or funder, regulatory due diligence examines whether regulatory, governance or operational weaknesses could affect service continuity, borrower performance, asset value, refinancing or the lender's exposure.
Regulatory Health Checks: Periodic independent assessments of regulated assets within a portfolio to identify emerging risks before formal enforcement intervention materially affects operational viability, transaction options or lender exposure.
Early Warning Analysis: Emerging indicators of operational and governance deterioration are identified at an early stage, allowing lenders and investors to consider their options before regulatory deterioration materially restricts them.
Portfolio reviews can identify service-level and cross-portfolio patterns involving leadership instability, repeated safeguarding concerns, weak governance assurance, staffing pressure, deteriorating commissioner relationships and unresolved regulatory actions. Findings can be prioritised by immediacy, regulatory significance and likely operational consequence for consideration by the portfolio owner or lender.
Distressed Asset & Turnaround
Focus: Urgent stabilisation, enforcement mitigation, and recovery.
48-Hour On-Site Assessment: Director-led deployment within 48 hours to establish the clinical, operational, governance and regulatory condition of a distressed service.
Stabilisation & Evidential Baselines: Director-level on-site leadership to stabilise failing services and build the contemporaneous evidential record required to support regulatory recovery.
Typical outputs
Depending on the instruction, outputs may include:
- a regulatory liability and risk-exposure report;
- a registration-continuity analysis;
- an independent operational baseline assessment;
- a governance and leadership stability assessment;
- a remediation exposure schedule identifying areas requiring specialist cost assessment;
- a portfolio regulatory health-check report;
- an early-warning risk briefing;
- a distressed-asset stabilisation report;
- a care-property regulatory assessment, where the instruction specifically includes the premises;
- a regulatory chronology;
- follow-up technical consultation.
The scope, intended audience, reporting format and permitted use of each document are agreed at the outset of the instruction.
Reporting scope and professional boundaries
Oxara provides independent clinical, operational, premises and regulatory-risk assessment. It does not provide accounting, investment, valuation, lending, insolvency, legal or surveying advice and does not determine transaction pricing or commercial strategy.
Oxara's findings are prepared for consideration by the appointed financial, legal, property and transaction professionals. The scope, intended audience, permitted use and reporting status of each output are agreed at the outset of the instruction.
Reports distinguish confirmed findings, evidence limitations, immediate regulatory risks and matters requiring advice from the appointed legal, financial, property or insolvency professionals.
All engagements are subject to formal conflict checks and handled with strict professional confidentiality.
Director-led delivery
Each instruction is led by an Oxara director with relevant clinical, operational, regulatory or transaction experience. Core assessment, site work, analysis and reporting are not delegated wholesale to junior consultants. The named instruction lead remains professionally accountable for the agreed work and final findings.
Instruction leadership
Roxana Rosca
Clinical governance, CQC regulation, service viability and regulatory recovery.
Emerson Kupfuwa
Multi-service operations, distressed-service stabilisation, leadership assessment and turnaround delivery.
Dr Sundeep Kaul PhD
Clinical governance systems, quality-risk scrutiny and evidence-based governance review.
Relevant experience
Financial and transaction instructions draw on the regulatory, operational and premises experience built through Oxara's case work. The matters below were not themselves transaction instructions; they are the source of the assessment experience applied to them.
How instructions are handled
- Conflict and independence check
- Scope and purpose of instruction agreed
- Secure document transfer
- Evidence review and clarification questions
- Site assessment where required
- Draft or final reporting
- Technical consultation with the appointed team